| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.093 | 0.5 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.5 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |